2019
DOI: 10.1016/j.biortech.2018.11.058
|View full text |Cite
|
Sign up to set email alerts
|

Effect of ciprofloxacin dosages on the performance of sponge membrane bioreactor treating hospital wastewater

Abstract: This study aimed to evaluate treatment performance and membrane fouling of a lab-scale Sponge-MBR under the added Ciprofloxacin (CIP) dosages (20; 50; 100 and 200 μg L-1) treating hospital wastewater. The results showed that Sponge-MBR exhibited effective removal of COD (94-98%) during the operation period despite increment of CIP concentrations from 20 to 200 μg L-1. The applied CIP dosage of 200 μg L-1 caused an inhibition of microorganisms in sponges, i.e. significant reduction of the attached biomass and a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
19
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 52 publications
(19 citation statements)
references
References 44 publications
0
19
0
Order By: Relevance
“…Worldwide, the various kinds of emerging pollutants such as pharmaceuticals compounds, anti-inflammatory drugs, antibiotics, beta-blockers [1] and the massive amount of NO 3 − or NO 2 − have attracted international attention for the last few decades [2]. Shown in Table 1, the antibiotic ciprofloxacin (CIP) is the 3rd-generation fluoroquinolone group usually used in humans and veterinarians [1,3,4]. The high-proportion of CIP is not fully metabolized in livestock and humans, but instead is evacuated as a parent substance [5].…”
Section: Introductionmentioning
confidence: 99%
See 3 more Smart Citations
“…Worldwide, the various kinds of emerging pollutants such as pharmaceuticals compounds, anti-inflammatory drugs, antibiotics, beta-blockers [1] and the massive amount of NO 3 − or NO 2 − have attracted international attention for the last few decades [2]. Shown in Table 1, the antibiotic ciprofloxacin (CIP) is the 3rd-generation fluoroquinolone group usually used in humans and veterinarians [1,3,4]. The high-proportion of CIP is not fully metabolized in livestock and humans, but instead is evacuated as a parent substance [5].…”
Section: Introductionmentioning
confidence: 99%
“…The high-proportion of CIP is not fully metabolized in livestock and humans, but instead is evacuated as a parent substance [5]. Hence, CIP can reach the environment through various pharmaceutical industries, sewage treatment plants, livestock activities, landfills, application of sewage sludge [6], manure or treated wastewater to agricultural land [3,7,8]. However, due to the potential development and dissemination of antibiotic resistance, this poses a potential threat to ecosystems and human health [2,3].…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…[6][7][8] Currently, there is great concern about multi-resistant bacteria occurring in wastewater treatment plants (WWTPs), since these units were not designed to remove ECs and provide an environment that is favorable for microorganism multiplication. 1,2,6,[9][10][11][12] It is known from the literature 2,13-17 that pharmaceutical compounds may be partially degraded (producing more toxic sub-products) or may remain unchanged during conventional treatment in WWTPs and then be released into water bodies. Within this perspective, ciprooxacin (CIP) has received great attention owing to its multi-resistant bacteria effect.…”
Section: Introductionmentioning
confidence: 99%